Compounded vs. Brand Name GLP-1 Medications
With brand-name GLP-1 medications like Ozempic and Mounjaro costing over $1,000 per month, compounded alternatives have become a lifeline for millions of patients. Here's a thorough comparison to help you make an informed decision.
The Cost Difference
The most significant difference between compounded and brand-name GLP-1 medications is price. Brand-name Wegovy (semaglutide for weight loss) has a list price of approximately $1,350 per month, while Zepbound (tirzepatide for weight loss) costs around $1,060 per month. Even with insurance, copays can run $200–$500 monthly, and many plans don't cover weight loss medications at all.
Compounded alternatives are dramatically more affordable. CoreAge Rx, for example, offers compounded semaglutide starting as low as $99/month and tirzepatide as low as $149/month — a savings of over 90% compared to brand-name options. Visit their website for the most current pricing and promotions.
| Factor | Brand Name | Compounded |
|---|---|---|
| Monthly Cost (Semaglutide) | $800–$1,350 | As low as $99 |
| Monthly Cost (Tirzepatide) | $1,000–$1,200 | As low as $149 |
| FDA Approved | Yes | No (FDA-registered facilities) |
| Active Ingredient | Same | Same |
| Insurance Coverage | Sometimes | HSA/FSA eligible |
| Availability | Frequent shortages | Generally available |
| Custom Dosing | Fixed pre-filled pens | Flexible custom doses |
| Combination Formulas | Not available | B12, NAD+, Lipo-C combos |
| Prescription Required | Yes | Yes |
Same Active Ingredient, Different Manufacturing
Both compounded and brand-name GLP-1 medications use the same active pharmaceutical ingredient. The difference lies in who manufactures them and under what regulatory framework. Brand-name drugs are manufactured by large pharmaceutical companies (Novo Nordisk for semaglutide, Eli Lilly for tirzepatide) under FDA approval for specific indications.
Compounded medications are prepared by licensed pharmacies — either 503A pharmacies (individual prescriptions) or 503B outsourcing facilities (bulk compounding under stricter FDA oversight). 503B facilities follow Current Good Manufacturing Practice (cGMP) guidelines, undergo regular FDA inspections, and test every batch for potency, sterility, and endotoxins. Read our guide to choosing a compounding pharmacy to understand what credentials to look for.
The FDA Approval Question
The most important distinction to understand: compounded GLP-1 medications are not FDA-approved products. This doesn't mean they're unregulated — 503B facilities operate under FDA registration and oversight — but they haven't gone through the same clinical trial process as brand-name drugs.
The FDA permits compounding when commercially available medications are in shortage or when a patient has a medical need for a customized formulation. As of 2024, both semaglutide and tirzepatide have been on the FDA's drug shortage list, which has enabled their compounding. Patients should understand this regulatory landscape and discuss it with their healthcare provider. Our review methodology evaluates pharmacy credentials as part of every listing.
Availability and Supply
One of the biggest drivers of the compounding market has been chronic shortages of brand-name GLP-1 medications. Since 2022, Ozempic, Wegovy, Mounjaro, and Zepbound have all experienced significant supply disruptions, leaving patients unable to fill prescriptions — sometimes for weeks or months at a time. These gaps in treatment can lead to weight regain and metabolic instability.
Compounding pharmacies can produce medications on demand, providing consistent supply without the manufacturing bottlenecks that affect brand-name drugs. For patients who need uninterrupted treatment, this reliability is often the deciding factor. See what patients are saying about their experiences with compounded medications.
Custom Formulations: A Unique Advantage
Compounding pharmacies can create formulations that aren't available from brand manufacturers. Popular combinations include:
- Semaglutide + Vitamin B12 — B12 supports energy levels during caloric deficit, addressing the fatigue many patients experience during weight loss.
- Tirzepatide + NAD+ — NAD+ (nicotinamide adenine dinucleotide) supports cellular energy metabolism and may help combat the fatigue associated with rapid weight loss.
- Custom intermediate doses — Brand-name pens come in fixed doses. Compounding allows for micro-adjustments (e.g., 0.375mg instead of jumping from 0.25mg to 0.5mg), enabling gentler titration for sensitive patients.
- Lipo-C combinations — Some pharmacies combine GLP-1 medications with lipotropic compounds that support fat metabolism.
How to Choose the Right Option
The choice between compounded and brand-name ultimately depends on your individual situation:
Brand-name may be right if:
- Your insurance covers it with an affordable copay
- You can reliably access supply at your pharmacy
- You prefer an FDA-approved product
- Your provider specifically recommends brand-name
Compounded may be right if:
- Brand-name is unaffordable or not covered by insurance
- You've experienced supply shortages with brand-name medications
- You want a custom formulation (B12, NAD+, intermediate dosing)
- You want to use HSA/FSA funds and avoid insurance complications
- You prefer the convenience of a telehealth + pharmacy model
Whichever path you choose, the key is working with a reputable provider. Browse our verified pharmacy listings and read real patient reviews to find the right fit.
Related Articles
Compare Compounding Pharmacies
Find the right pharmacy with transparent pricing and verified patient reviews.